Parameter | Age: ā„18āmonths | Stage: M | Hist.D: uNB/pdNB | MYCN: MNA | Gen. profile: SCA | 11q: 11qD | Risk group: high-risk | Gen. Instab.:High |
---|
IPP | Nuclei | Dens. | ā | 0.005ā | 0.007ā | 0.001ā | ā | ā | 0.001ā | 0.003ā |
%SA | 0.004ā | ā | ā | ā | 0.018ā | ā | ā | ā |
Inter.VN | %SA | ā | ā | ā | ā | ā | ā | ā | ā |
Terr.VN | %SA | ā | 0.010ā | 0.001ā* | 0.024ā | 0.001ā | 0.035ā | 0.008ā | 0.000ā |
Densito | VN ratio of pixels | Weak | ā | ā | ā | ā | ā | ā | ā | ā |
Mod. | ā | ā | ā | ā | ā | ā | ā | ā |
Strong | ā | 0.037ā | 0.010ā* | 0.011ā | 0.002ā | 0.021ā | 0.004ā | 0.010 ā |
H-score | ā | ā | 0.019ā | 0.040ā | 0.011ā | ā | 0.008ā | 0.001ā |
- Only morphometric variables for vitronectin (VN) expression and nuclei having a statistically significant relationship with pre-treatment risk stratification factors are shown (p-value<ā0.05). IPP: Image Pro-Plus; Densito: DensitoQuant; Dens. Density (number of objects/mm2); %SA: percentage of stained area; Inter. VN: Interterritorial VN; Terr.VN: Territorial VN; Mod.: moderate. M: metastatic; Hist.D: histopathologic differentiation; uNB: undifferentiated neuroblastoma; pdNB: poorly differentiated neuroblastoma; NOS was excluded from statistical analysis; Gen. Profile: genetic profile; SCA: segmental chromosomal aberration; MNA: MYCN amplified; 11qD: 11q deletion; Gen. Instab.: genetic instability. -: not statistically significant, ā/ā: higher or lower median value for the poor-prognostic group(s). *There are statistically significant differences between pdNB and uNB, within Strong VN (p-value<ā0.05) and %SA Territorial VN (p-value<ā0.1) morphometric variables